Search Results - Rachel Ingraham
- Showing 1 - 4 results of 4
-
1
-
2
-
3
mTOR and HDAC Inhibitors Converge on the TXNIP/Thioredoxin Pathway to Cause Catastrophic Oxidative Stress and Regression of RAS-Driven Tumors by Clare F. Malone, Chloe E. Emerson, Rachel Ingraham, William Barbosa, Stephanie Guerra, Haejin Yoon, Lin Liu, Franziska Michor, Marcia C. Haigis, Kay F. Macleod, Ophélia Maertens, Karen Cichowski
Published 2017Artigo -
4
CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer by Elda Righi, Satoshi Kashiwagi, J. P. Yuan, Michael Santosuosso, Pierre Leblanc, Rachel Ingraham, Benjamin Forbes, Beth Edelblute, Brian Collette, Deyin Xing, Magdalena Kowalski, Maria Cristina Mingari, Fabrizio Vianello, Michael J. Birrer, Sandra Oršulić, Glenn Dranoff, Mark C. Poznansky
Published 2011Artigo
Search Tools:
Related Subjects
Biology
Cancer
Cancer research
Cell biology
Genetics
PI3K/AKT/mTOR pathway
Signal transduction
Neurofibromin 1
mTORC1
Angiogenesis
Biochemistry
CXCR4
CXCR4 antagonist
Cabozantinib
Chemokine
Colorectal cancer
Effector
FOXP3
Gene
Immune system
Immunology
Internal medicine
KRAS
Kinase
MAPK/ERK pathway
Malignant peripheral nerve sheath tumor
Medicine
Mutant
Nerve sheath neoplasm
Neurofibromatosis